Abiopharma

BridgeBio to Present Primary Results from Phase 3 PROPEL 3 Trial of Oral Infigratinib for Children Living with Achondroplasia at ICCBH 2026

Became an interested party – Leumi Partners Ltd.

Register of shareholders, changes and capital status – payment of partial early redemption – Hapoalim BONDS 1 – RM

FORTESCUE AND CMB.TECH SIGN MILESTONE AGREEMENT FOR 12 AMMONIA BULKERS TO ACCELERATE ZERO-EMISSIONS SHIPPING

Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D

Communiqué de presse : Sanofi nomme Paulo Fontoura à la tête de sa R&D

ArcelorMittal announces strategic collaboration with AWS to drive industrial automation and lower-carbon construction globally

Net Asset Value(s)

Sale of Non-Core Businesses

FLSmidth: Transactions under share buy-back programme